INTRODUCTION
Daptomycin is a cyclic lipopeptide antibiotic approved for the treatment of complicated skin and skin structure infections, as well as for Staphylococcus aureus bloodstream infections, including those occurring with right-sided infective endocarditis [1, 2] . Data analyses from the EU-CORE registry consisting of 6075 patients indicate that daptomycin is relatively safe and well tolerated, even at high doses ([6 mg/kg/day) [3] . Serious adverse events possibly related to daptomycin occurred in B2% of patients, but hypersensitivity reactions were rare [3] . The precise clinical manifestations of these hypersensitivity reactions are not described. These registry data are important, in particular when facing a previously undescribed adverse event to a compound. Here, we report a case of acute angioedema triggered by daptomycin.
CASE REPORT
A 60-year-old woman was admitted to our hospital because of immobilizing lumbar back pain and elevated inflammatory markers in blood tests. Spine infection was suspected, and after obtaining blood cultures, the patient was treated empirical therapy with ceftriaxone (2 g once daily). Growth of Gram-positive cocci was detected in all blood culture samples. Informed consent was obtained from the patient for being included in this case report.
DISCUSSION
To the best of our knowledge, this is the first report of angioedema after daptomycin exposure. A literature review identified only three published cases of immediate-type hypersensitivity reactions to daptomycin.
Bagwell et al. [6] reported a 24-year-old woman with multiple antibiotic allergies. She had experienced hypersensitivity reactions to daptomycin previously, and after re-exposure, pruritus and shortness of breath developed.
Metz and Thyagarajan described a 33-year-old man who did not tolerate vancomycin because of a diffuse urticarial eruption [7] . After the third daptomycin administration, he developed a generalized urticarial rash (no lip or tongue swelling or shortness of breath). His symptoms improved with diphenhydramine, but the urticarial rash returned after each subsequent dose. On the basis of the reported patient history, it is unclear whether this reaction was IgE mediated or nonspecific (e.g., mast cell activation). The third case illustrates desensitization to ceftaroline in a 32-year-old woman with multiple allergies, including anaphylaxis to daptomycin (not further specified) [8] . In contrast to these cases, our patient had no known allergy, and angioedema developed acutely after the first dose. In addition, the association with daptomycin was suggested by a positive IDT result. In the present case, the more frequently reported association of beta-lactams with hypersensitivity reactions [16] and the lack of a similar case report associated with daptomycin were misleading. When performing an IDT, a procedure with sequent dilutions is recommended (10 ) [17] . We performed the IDT in the ICU with a 10 -1 dilution of the original vial concentration (50 mg/mL) and all necessary precautions were taken in case emergency treatment was needed. As done in our investigations, healthy volunteers with or without previous exposure to the drug can be used as negative controls to evaluate nonspecific skin reaction [17] . Although one healthy control may be insufficient to draw firm conclusions, the IDT result and a negative control was a helpful tool-together with the clinical observation and detailed time analyses of drug application-in pointing towards a daptomycin-associated hypersensitivity reaction. Because of the clinical circumstances, no in vitro testing with specific IgE level measurements to daptomycin could be performed, and no tryptase was measured. Although, in our view, IgE-mediated reaction is likely, it cannot be ascertained. Therefore, the association with daptomycin is either probable or certain.
CONCLUSION
Daptomycin is relatively safe and well tolerated. Serious adverse events are rarely reported. 
